CAS 76824-35-6
:Famotidin
- 3-[(2-Diaminomethyleneaminothiazol-4-yl)methylthio]-N-sulfamoylpropionamidine
- 3-[([2-[(Diaminomethylidene)amino]-1,3-thiazol-4-yl]methyl)sulfanyl]-N-sulfamoylpropanimidamide
- 3-[({2-[(Hydrazonomethyl)amino]thiazol-4-yl}methyl)thio]-N-sulfamoylpropionamidine
- 3-[[2-(Diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N′-sulfamoylpropanimidamide
- 3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)propanimidamide
- Agufam
- Amfamox
- Antodine
- Apo-Famotidine
- Apogastine
- Bestidine
- Brolin
- Cepal
- Digervin
- Dispromil
- Dispronil
- Durater
- Facid
- Fadin
- Fadine
- Fadyn
- Fagastine
- Famo
- FamoABZ
- Famocid
- Famodar
- Famodil
- Famodin
- Famodine
- Famogard
- Famogast
- Famolta
- Famonerton
- Famopsin
- Famos
- Famosan
- Famoser
- Famostagine-D
- Famotal
- Famotep
- Famotin
- Famotine
- Famowal
- Famox
- Famoxal
- Fanosin
- Fanox
- Farmotex
- Fenox
- Fibonel
- Fudone
- Fuweidin
- Ganor
- Gaster
- Gastridin
- Gastrion
- Gastro
- Gastrodomina
- Gastropen
- Ifada
- Kemofam
- Lecedil
- Logos
- Mosul
- Motiax
- Muclox
- N-(Aminosulfonyl)-3-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]propanimidamide
- Nevofam
- Nulcerin
- Panalba
- Pepcid
- Pepcidin
- Pepcidina
- Pepcidine
- Pepdif
- Pepdine
- Pepdul
- Pepfamin
- Peptan
- Peptec
- Peptifam
- Pepzan
- Purifam
- Quamatel
- Quamtel
- Restadin
- Rogasti
- Servipep
- Supertidine
- Tamin
- Topcid
- Ulcatif
- Ulcedine
- Ulceran
- Ulcetrax
- Ulcidine
- Ulcofam
- Ulfagel
- Ulfam
- Ulfamid
- Ulfinol
- Ulped
- Weimok
- [Amino-3-[[[2-[(Diaminomethylene)Amino]-4-Thiazolyl]-Methyl]Thio]Propylidene]
- Propanimidamide, 3-[[[2-[(aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)-
- Famotidine
- Famotidine (Patented-No Supply)
- Weitere Synonyme anzeigen
Famotidine
CAS:Formel:C8H15N7O2S3Reinheit:>98.0%(T)(HPLC)Farbe und Form:White to Almost white powder to crystalMolekulargewicht:337.44Famotidine, 98+%
CAS:A competitive histamine H2 receptor antagonist
Formel:C8H15N7O2S3Reinheit:98+%Molekulargewicht:337.45Famotidine
CAS:FamotidineFormel:C8H15N7O2S3Reinheit:99.7%Farbe und Form:White. To. Off-WhiteMolekulargewicht:337.04494FAMOTIDINE FOR SYSTEM SUITABILITY CRS
CAS:FAMOTIDINE FOR SYSTEM SUITABILITY CRSFormel:C8H15N7O2S3Molekulargewicht:337.4454Famotidine
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormel:C8H15N7O2S3Farbe und Form:PowderMolekulargewicht:337.45Famotidine
CAS:Famotidine, a histamine H2-blocker, curbs gastric acid production, lowering volume and acidity.Formel:C8H15N7O2S3Reinheit:98.93% - 99.91%Farbe und Form:White To Off-White Crystalline PowderMolekulargewicht:337.453-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide
CAS:Formel:C8H15N7O2S3Reinheit:97%Farbe und Form:SolidMolekulargewicht:337.4454Ref: IN-DA003QKN
1g24,00€5g52,00€15g106,00€1kgNachfragen25g129,00€2kgNachfragen100g297,00€500gNachfragenFamotidine
CAS:Formel:C8H15N7O2S3Reinheit:≥ 98.0%Farbe und Form:White to off-white powderMolekulargewicht:337.45Famotidine-d4 (Major)
CAS:Kontrolliertes ProduktApplications Famotidine-d4 is the labeled analogue of Famotidine (F102250), a histamine H2-receptor antagonist. Antiulcerative.
References Takeda, M., et al.: Arzneim.-Forsch., 32, 734 (1982); Miwa, M., et al.: J. Clin. Pharmacol. Ther. Toxicol., 22, 214 (1984); Takabatke, T., et al.: Eur. J. Clin. Pharmacol., 28, 327 (1985)Formel:C8H11D4N7O2S3Farbe und Form:NeatMolekulargewicht:341.47Famotidine
CAS:Kontrolliertes ProduktApplications Histamine H2-receptor antagonist. Antiulcerative.
References Takeda, M., et al.: Arzneim.-Forsch., 32, 734 (1982), Miwa, M., et al.: J. Clin. Pharmacol. Ther. Toxicol., 22, 214 (1984), Takabatke, T., et al.: Eur. J. Clin. Pharmacol., 28, 327 (1985),Formel:C8H15N7O2S3Farbe und Form:White To Off-WhiteMolekulargewicht:337.45Famotidine
CAS:Famotidine is a selective histamine H2-receptor antagonist used in the treatment of gastric hypersecretory disorders. Famotidine is effective in the treatment of duodenal and gastric ulcers, particularly when they are caused by the prolonged use of nonsteroidal antiinflammatory drugs (NSAIDs). To improve retention in the stomach, famotidine has experimentally been formulated as buoyant tablets that remained floating for up to 10 hours in vitro (Jaimini, 2007).
Formel:C8H15N7O2S3Reinheit:Min. 98 Area-%Farbe und Form:White PowderMolekulargewicht:337.45 g/mol3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide
CAS:Formel:C8H15N7O2S3Reinheit:97%Molekulargewicht:337.44















